An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD

Clinical trial NCT06022744 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06022744
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD

Start date: 2023-09-01
Primary completion: 2025-09-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.